Humacyte Inc.

NASDAQ: HUMA · Real-Time Price · USD
1.89
0.01 (0.53%)
At close: Aug 15, 2025, 3:47 PM

Humacyte Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
44.94M 80.45M 149.77M 217.5M
Short-Term Investments
n/a n/a 2.11M 8M
Long-Term Investments
50.21M 209K n/a n/a
Other Long-Term Assets
1.25M -209K n/a n/a
Receivables
n/a n/a 31K 176K
Inventory
n/a n/a n/a n/a
Other Current Assets
2.92M 144K n/a n/a
Total Current Assets
47.86M 83.28M 154.21M 229.34M
Property-Plant & Equipment
38.55M 44.95M 50.09M 57.19M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
90.01M 44.95M 50.09M 57.19M
Total Assets
137.87M 128.22M 204.3M 286.53M
Account Payables
4.49M 6.49M 1.59M 2.09M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
900K 2.61M 8.57M 2.03M
Other Current Liabilities
118K -2.56M n/a 961K
Total Current Liabilities
19.95M 18.44M 19.58M 11.05M
Long-Term Debt
63.35M 38.6M 20.34M 27.36M
Other Long-Term Liabilities
93.11M 40.74M 28M 104.16M
Total Long-Term Liabilities
170.59M 96.23M 67.79M 153.31M
Total Liabilities
190.54M 114.68M 87.37M 164.36M
Total Debt
16.54M 58.05M 50.67M 51.18M
Common Stock
13K 10K 10K 536.75M
Retained Earnings
-686.01M -537.31M -426.54M -414.57M
Comprehensive Income
n/a n/a n/a -822.77M
Shareholders Equity
-52.67M 13.55M 116.93M 122.17M
Total Investments
50.21M 209K 2.11M 8M